Logo image of TDAC

TRANSLATIONAL DEVELOPMENT AC (TDAC) Stock Fundamental Analysis

USA - NASDAQ:TDAC - KYG9008W1050 - Common Stock

10.34 USD
+0.01 (+0.1%)
Last: 9/10/2025, 12:53:43 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TDAC. TDAC was compared to 0 industry peers in the Unkown industry. While TDAC seems to be doing ok healthwise, there are quite some concerns on its profitability. TDAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TDAC was profitable.
In the past year TDAC has reported a negative cash flow from operations.
TDAC Yearly Net Income VS EBIT VS OCF VS FCFTDAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -200K -400K -600K -800K

1.2 Ratios

Industry RankSector Rank
ROA 1.7%
ROE 1.77%
ROIC N/A
ROA(3y)-8096.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TDAC Yearly ROA, ROE, ROICTDAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -5K -10K -15K -20K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TDAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TDAC Yearly Profit, Operating, Gross MarginsTDAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

TDAC has about the same amout of shares outstanding than it did 1 year ago.
TDAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TDAC Yearly Shares OutstandingTDAC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
TDAC Yearly Total Debt VS Total AssetsTDAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 21.44 indicates that TDAC is not in any danger for bankruptcy at the moment.
There is no outstanding debt for TDAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.44
ROIC/WACCN/A
WACCN/A
TDAC Yearly LT Debt VS Equity VS FCFTDAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.55 indicates that TDAC may have some problems paying its short term obligations.
TDAC has a Quick Ratio of 0.55. This is a bad value and indicates that TDAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
TDAC Yearly Current Assets VS Current LiabilitesTDAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200K 400K 600K

More info and screens

1

3. Growth

3.1 Past

TDAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.49%, which is quite impressive.
EPS 1Y (TTM)85.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TDAC Yearly Revenue VS EstimatesTDAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 100M 200M 300M 400M
TDAC Yearly EPS VS EstimatesTDAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0.1 0.2 0.3 0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 73.86, which means the current valuation is very expensive for TDAC.
The average S&P500 Price/Earnings ratio is at 27.30. TDAC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 73.86
Fwd PE N/A
TDAC Price Earnings VS Forward Price EarningsTDAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TDAC Per share dataTDAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TDAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRANSLATIONAL DEVELOPMENT AC

NASDAQ:TDAC (9/10/2025, 12:53:43 PM)

10.34

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-14 2025-08-14
Earnings (Next)12-08 2025-12-08
Inst Owners78.59%
Inst Owner Change30.2%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap226.55M
Analysts100
Price TargetN/A
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 73.86
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.14
EY1.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS7.84
TBVpS7.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.7%
ROE 1.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8096.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 21.44
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-425650%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-425650%
OCF growth 3YN/A
OCF growth 5YN/A